Physician profile
Mana Baskovic
NPI 1750742698
$4,361.77
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.79 · 2021: $445 · 2022: $3,265 · 2023: $344 · 2024: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,025.48 | 2022-2023 | Da Vinci Surgical System |
| Abbvie INC. | $257.12 | 2020-2022 | |
| Pfizer INC. | $162.76 | 2023-2024 | |
| Novo Nordisk INC | $120.23 | 2024 | Wegovy |
| Myovant Sciences INC. | $110.36 | 2021-2022 | |
| Evofem Biosciences, INC. | $88.15 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $78.87 | 2023 | Myfembree |
| Becton, Dickinson and Company | $73.98 | 2023-2024 | Bd Onclarity |
| Therapeuticsmd, INC. | $72.36 | 2021-2022 | |
| Hologic Sales and Service, LLC | $63.61 | 2022-2023 | Aptima |
| Janssen Pharmaceuticals, INC | $63.37 | 2021-2023 | Xarelto |
| Myriad Women'S Health, INC. | $41.88 | 2023 | |
| Mayne Pharma Commercial LLC | $39.00 | 2023 | |
| Astellas Pharma US INC | $25.61 | 2024 | Veozah |
| Agile Therapeutics, INC. | $24.32 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $24.17 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $23.03 | 2022 | |
| Amgen INC. | $22.83 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.32 | 2022 | |
| Applied Medical Resources Corporation | $11.54 | 2021 | |
| Organon LLC | $10.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mana Baskovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.